2020
DOI: 10.1016/j.jece.2020.103777
|View full text |Cite
|
Sign up to set email alerts
|

Treatment of pharmaceutical wastewater by combination of electrocoagulation, electro-fenton and photocatalytic oxidation processes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(15 citation statements)
references
References 56 publications
0
14
0
1
Order By: Relevance
“…Additionally, biological systems can be more effective in terms of removing organic matter in wastewater from the pharmaceutical industry when compared to studies where coagulation is used, and the removal of COD was only 49 % [35,36]. Other authors apply for treatment of pharmaceutical industry wastewater a combination into electrocoagulation, electro-Fenton, and photocatalytic oxidation, where the effective remotion was observed 64 % total organic carbon and 70.2 % COD [37]; for remotion of 99 % COD in wastewater pharmaceutical industry combination between micro-electrolysis and Fenton oxidation-coagulation, this study needed 90 days to almost remove COD wholly [38]. In the future, a possible combination of physicochemical technologies with a biological treatment could reduce the time of COD remotion and additionally remove Emerging Pollutants in wastewater.…”
Section: Organic Matter Removal Tests In Ndww Of the Pharmaceutical Industrymentioning
confidence: 99%
“…Additionally, biological systems can be more effective in terms of removing organic matter in wastewater from the pharmaceutical industry when compared to studies where coagulation is used, and the removal of COD was only 49 % [35,36]. Other authors apply for treatment of pharmaceutical industry wastewater a combination into electrocoagulation, electro-Fenton, and photocatalytic oxidation, where the effective remotion was observed 64 % total organic carbon and 70.2 % COD [37]; for remotion of 99 % COD in wastewater pharmaceutical industry combination between micro-electrolysis and Fenton oxidation-coagulation, this study needed 90 days to almost remove COD wholly [38]. In the future, a possible combination of physicochemical technologies with a biological treatment could reduce the time of COD remotion and additionally remove Emerging Pollutants in wastewater.…”
Section: Organic Matter Removal Tests In Ndww Of the Pharmaceutical Industrymentioning
confidence: 99%
“…PWW, chiefly chemical pharmaceutical wastewater, has now converted into most hard-to-manage and risky categories of wastewater [39]. Pharmaceutical wastewater possesses small amount of biochemical oxygen demand (BOD) and greater concentration of chemical oxygen demand (COD) in pharmaceutical wastewater [8].…”
Section: Characteristics Of Pharmaceutical Wastewater (Pww)mentioning
confidence: 99%
“…In a study, the pharmaceutical treatment was evaluated by grouping of photocatalytic oxidation (PcO), electroFenton (EF), and electrocoagulation (EC) procedures. Furthermore, the effect of procedure order and reaction duration, current concentration for EF and EC procedures utilizing iron plate electrodes and lastly photocatalytic action of various catalysts for PcO procedure were inspected in order to remove total organic carbon [8].…”
Section: Hybrid Systems (Hss)mentioning
confidence: 99%
“…Además, los procesos de elaboración de estas sustancias son llevados a cabo por lotes, situación que da como resultado aguas residuales de composición compleja y fuertes fluctuaciones en la concentración de contaminantes (Ling et al, 2020). La baja biodegradabilidad de estos productos hace que las aguas residuales que los contienen presenten bajos valores de DBO y altos valores de DQO, lo cual representa un inconveniente para el tratamiento biológico de dichas aguas, puesto que los compuestos químicos recalcitrantes pueden restringir la actividad de los microorganismos (Başaran-Dindaş et al, 2020). De esta manera, las aguas residuales generadas por las empresas farmacéuticas tienden a ser refractarias a la mayoría de las técnicas de tratamiento físico, químico y biológico convencionales.…”
Section: Introductionunclassified